Purchase Short-Term Access

Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy
Tomas Berl, MD; Lawrence G. Hunsicker, MD; Julia B. Lewis, MD; Marc A. Pfeffer, MD, PhD; Jerome G. Porush, MD; Jean-Lucien Rouleau, MD; Paul L. Drury, MD, FRACP; Enric Esmatjes, MD; Donald Hricik, MD; Chirag R. Parikh, MD; Itamar Raz, MD; Philippe Vanhille, MD; Thomas B. Wiegmann, MD; Bernard M. Wolfe, MD, FRCPC; Francesco Locatelli, MD; Samuel Z. Goldhaber, MD; Edmund J. Lewis, MD; Collaborative Study Group*
Annals of Internal Medicine 2003;138:542-549. doi:10.7326/0003-4819-138-7-200304010-00010

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.